ストックスクリーナーアプリを入手
2.42
1.22%
-0.03
アフターアワーズ：
2.40
-0.02
-0.83%
前日終値:
$2.45
開ける：
$2.45
24時間の取引高:
9.09M
Relative Volume:
0.59
時価総額：
$875.69M
収益：
$32.77M
当期純損益:
$-440.22M
株価収益率:
-1.4491
EPS:
-1.67
ネットキャッシュフロー:
$-400.48M
1週間 パフォーマンス:
-4.35%
1か月 パフォーマンス:
-22.68%
6か月 パフォーマンス:
-53.99%
1年 パフォーマンス:
-78.77%
1日の値動き範囲:
$2.35
$2.50
1週間の範囲:
$2.35
$2.76
52週間の値動き範囲:
$1.6385
$12.51
Iovance Biotherapeutics Inc Stock (IOVA) Company Profile
名前
Iovance Biotherapeutics Inc
セクター
電話
(650) 260-7120
住所
825 INDUSTRIAL ROAD, SAN CARLOS
IOVA を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
IOVA
Iovance Biotherapeutics Inc
|
2.42 | 886.54M | 32.77M | -440.22M | -400.48M | -1.67 |
|
VRTX
Vertex Pharmaceuticals Inc
|
389.08 | 99.27B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
586.96 | 62.28B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
454.18 | 59.14B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
707.96 | 43.34B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
300.14 | 36.72B | 3.81B | -644.79M | -669.77M | -6.24 |
Iovance Biotherapeutics Inc Stock (IOVA) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-07-15 | ダウングレード | Goldman | Neutral → Sell |
| 2025-05-16 | ダウングレード | UBS | Buy → Neutral |
| 2025-05-12 | ダウングレード | Truist | Buy → Hold |
| 2025-05-09 | ダウングレード | Citizens JMP | Mkt Outperform → Mkt Perform |
| 2024-10-24 | 開始されました | UBS | Buy |
| 2024-07-29 | ダウングレード | Piper Sandler | Overweight → Neutral |
| 2023-11-20 | 開始されました | Goldman | Buy |
| 2023-09-18 | 繰り返されました | Barclays | Overweight |
| 2023-05-30 | アップグレード | Wells Fargo | Equal Weight → Overweight |
| 2023-03-27 | 再開されました | Wells Fargo | Equal Weight |
| 2023-01-27 | アップグレード | Piper Sandler | Neutral → Overweight |
| 2022-12-09 | ダウングレード | Goldman | Buy → Neutral |
| 2022-10-31 | 開始されました | Guggenheim | Neutral |
| 2022-08-18 | 再開されました | Wells Fargo | Equal Weight |
| 2022-01-28 | アップグレード | Stifel | Hold → Buy |
| 2021-12-07 | 再開されました | Cowen | Outperform |
| 2021-06-10 | アップグレード | JMP Securities | Mkt Perform → Mkt Outperform |
| 2021-05-20 | ダウングレード | Piper Sandler | Overweight → Neutral |
| 2021-05-19 | ダウングレード | JMP Securities | Mkt Outperform → Mkt Perform |
| 2021-05-19 | ダウングレード | Stifel | Buy → Hold |
| 2021-05-03 | 開始されました | Truist | Buy |
| 2021-04-16 | 開始されました | Goldman | Buy |
| 2021-03-08 | アップグレード | H.C. Wainwright | Neutral → Buy |
| 2020-12-15 | ダウングレード | H.C. Wainwright | Buy → Neutral |
| 2020-10-06 | ダウングレード | Wells Fargo | Overweight → Equal Weight |
| 2020-04-22 | 開始されました | Mizuho | Buy |
| 2020-03-04 | 開始されました | Barclays | Overweight |
| 2020-02-26 | 繰り返されました | H.C. Wainwright | Buy |
| 2020-02-26 | 繰り返されました | Oppenheimer | Outperform |
| 2019-12-18 | 開始されました | JMP Securities | Mkt Outperform |
| 2019-10-01 | 開始されました | Stifel | Buy |
| 2019-04-29 | 開始されました | Piper Jaffray | Overweight |
| 2019-02-28 | 繰り返されました | Chardan Capital Markets | Buy |
| 2019-02-07 | 開始されました | Robert W. Baird | Outperform |
| 2018-12-31 | 再開されました | B. Riley FBR | Buy |
| 2018-07-06 | 繰り返されました | Chardan Capital Markets | Buy |
| 2018-04-10 | アップグレード | B. Riley FBR, Inc. | Neutral → Buy |
| 2018-03-13 | 繰り返されました | B. Riley FBR, Inc. | Neutral |
| 2018-02-23 | ダウングレード | B. Riley FBR, Inc. | Buy → Neutral |
| 2018-01-25 | 繰り返されました | H.C. Wainwright | Buy |
| 2017-11-01 | 繰り返されました | B. Riley FBR, Inc. | Buy |
すべてを表示
Iovance Biotherapeutics Inc (IOVA) 最新ニュース
Will Iovance Biotherapeutics Inc. bounce back from current support2025 Volatility Report & Community Shared Stock Ideas - Newser
How to build a custom watchlist for Iovance Biotherapeutics Inc.Trade Performance Summary & Comprehensive Market Scan Reports - Newser
Is this a good reentry point in Iovance Biotherapeutics Inc.Weekly Profit Recap & Daily Volume Surge Signals - Newser
Iovance Biotherapeutics: Is the Stock's Plunge a Buying Opportunity or a Warning Sign? - AInvest
Iovance: Thin Margins, Dilution Threat Keep Risk-Skewed (NASDAQ:IOVA) - Seeking Alpha
Risk vs reward if holding onto Iovance Biotherapeutics Inc.Long Setup & Accurate Technical Buy Alerts - Newser
Can momentum traders help lift Iovance Biotherapeutics Inc.2025 Earnings Surprises & Capital Efficiency Focused Strategies - Newser
Visualizing Iovance Biotherapeutics Inc. stock with heatmapsJuly 2025 PreEarnings & Accurate Intraday Trade Tips - Newser
Key resistance and support levels for Iovance Biotherapeutics Inc.2025 Earnings Surprises & Stepwise Trade Signal Implementation - Newser
Is Iovance Biotherapeutics Inc. a candidate for recovery playPortfolio Value Summary & Growth Focused Stock Pick Reports - Newser
Is Iovance Biotherapeutics Inc. forming a bottoming baseJuly 2025 Highlights & AI Based Buy/Sell Signal Reports - Newser
Multi factor analysis applied to Iovance Biotherapeutics Inc.July 2025 Reactions & Free Safe Capital Growth Stock Tips - Newser
How to monitor Iovance Biotherapeutics Inc. with trend dashboardsWeekly Trade Review & Fast Moving Stock Trade Plans - Newser
Will Iovance Biotherapeutics Inc. continue its uptrend2025 Market Trends & Weekly Watchlist for Hot Stocks - Newser
Combining machine learning predictions for Iovance Biotherapeutics Inc.July 2025 PreEarnings & Long Hold Capital Preservation Plans - Newser
How to forecast Iovance Biotherapeutics Inc. trends using time seriesWeekly Trade Recap & Risk Controlled Swing Alerts - Newser
What to do if you’re stuck in Iovance Biotherapeutics Inc.Rate Cut & Low Risk Growth Stock Ideas - Newser
Iovance Biotherapeutics Inc. stock daily chart insightsDollar Strength & Community Driven Trade Alerts - Newser
Untreated Metastatic or Unresectable Melanoma Clinical Trial Pipeline Expands as 10+ Companies Driving Innovation in Oncology Therapeutics Space | DelveInsight - GlobeNewswire Inc.
Can Iovance Biotherapeutics Inc. rally from current levelsJuly 2025 Institutional & Expert Approved Trade Ideas - Newser
Iovance Biotherapeutics Secondary Stock Offering: A $350M Deal with a 6% Share Price Drop - AInvest
IOVA Stock Drops 6% on $350M Common Stock Offering - TradingView
Building trade automation scripts for Iovance Biotherapeutics Inc.Recession Risk & Long-Term Safe Investment Plans - Newser
Reversal indicators forming on Iovance Biotherapeutics Inc. stockBear Alert & Community Trade Idea Sharing - Newser
Will Iovance Biotherapeutics Inc. benefit from macro trendsJuly 2025 Highlights & AI Driven Price Predictions - Newser
Chart based analysis of Iovance Biotherapeutics Inc. trendsExit Point & AI Powered Buy/Sell Recommendations - Newser
Is Iovance Biotherapeutics Stock Due for a Big Rally? - MSN
Why Iovance Biotherapeutics Stock Got Mashed on Monday - AOL.com
Artisan Small Cap Fund Exited Its Stake in Iovance Biotherapeutics (IOVA) Due to Operational Challenges - Insider Monkey
Iovance Biotherapeutics Grants Stock Options to New Employees Under NASDAQ Listing Rule 5635(c)(4) - AInvest
1 Beaten-Down Stock That Could Soar By 261%, According to Wall Street - AOL.com
Price momentum metrics for Iovance Biotherapeutics Inc. explainedJuly 2025 Drop Watch & AI Powered Market Entry Strategies - Newser
Is Iovance Biotherapeutics Inc. stock entering bullish territoryStop Loss & Stepwise Swing Trade Plans - Newser
Iovance Biotherapeutics (IOVA) Receives Conditional Approval From Health Canada - MSN
Iovance Biotherapeutics' $350M ATM Financing: A High-Stakes Bet on Amtagvi's Future - AInvest
Iovance Biotherapeutics Amends Sale Agreement with Jefferies - TipRanks
Iovance Biotherapeutics Grants Inducement Stock Options to New Employees - Quiver Quantitative
Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4) - GlobeNewswire
How to escape a deep drawdown in Iovance Biotherapeutics Inc.Analyst Downgrade & Fast Entry High Yield Stock Tips - Newser
Iovance Biotherapeutics: Navigating the High-Risk, High-Reward Path of Amtagvi Global Expansion - AInvest
Iovance Biotherapeutics: Tough Decisions Being Made But Catalysts In H2'25 (NASDAQ:IOVA) - Seeking Alpha
Detecting support and resistance levels for Iovance Biotherapeutics Inc.Weekly Market Report & Safe Entry Point Identification - Newser
Around the Helix: Cell and Gene Therapy Company Updates – August 20, 2025 - CGTLive®
Iovance Biotherapeutics Receives Health Canada Approval for Amtagvi in Advanced Melanoma Patients - AInvest
Statistical indicators supporting Iovance Biotherapeutics Inc.’s strengthPortfolio Risk Report & Real-Time Market Trend Scan - Newser
Is Iovance Biotherapeutics Inc. showing signs of accumulationOptions Play & High Win Rate Trade Alerts - Newser
Iovance Biotherapeutics Gains Health Canada Approval - MSN
Iovance Biotherapeutics Inc (IOVA) 財務データ
収益
当期純利益
現金流量
EPS
0.98%
8.06%
大文字化:
|
ボリューム (24 時間):